July 7, 2025
HYDERABAD (Reuters) -Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market share, […]
July 7, 2025
TOPLINE: Measuring copeptin levels in patients with hypotonic hyponatremia on emergency department (ED) admission provided key diagnostic insights. The copeptin to urinary sodium ratio more accurately […]
July 7, 2025
TOPLINE: Patients with type 2 diabetes (T2D) had approximately 20%-26% higher mortality rates following ischemic and nonischemic heart failure (HF) than those without diabetes, with similar […]
July 3, 2025
TOPLINE: High emotional demands and confrontational interactions in person-related work were associated with a substantial 15%-24% increased risk for type 2 diabetes (T2D) in both men […]
July 3, 2025
TOPLINE: In children aged 2-6 years with type 1 diabetes (T1D) who required at least six units of insulin daily, using the auto mode of the […]
July 3, 2025
TOPLINE: MRI-based screening in patients older than 50 years with new-onset or deteriorating diabetes detected stage IB pancreatic cancer in a patient with deteriorating diabetes, highlighting […]
July 2, 2025
TOPLINE: Once-weekly IcoSema — a combination of basal insulin icodec and the GLP-1 receptor agonist semaglutide — achieved a noninferior reduction in A1c levels compared with […]
July 1, 2025
COPENHAGEN (Reuters) -Novo Nordisk’s top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the […]
June 30, 2025
Intermittent fasting has gained popularity among individuals who want to lose weight. While this approach has shown promising results, it may not be the best eating […]